AstraZeneca announces that Voydeya has been approved in the U.S. as an adjunctive therapy to Ultomiris or Soliris in the treatment of extravascular hemolysis in adults with paroxysmal nocturnal.
McCann FitzGerald LLP welcomed 300 guests to its recent 2023 In-House Counsel Conference in Dublin’s Marker Hotel, which included a series of discussions focused on the theme of "legal practice in an evolving environment". The half-day event was designed to address the key challenges and conce
New York, NY (PRWEB) January 10, 2023 - Makes major investment in Phase 2b Clinical Trial at NFlection Therapeutics- Topical MEK inhibitor NFX-179 Shows
An examination of the most consequential features of the merger control regime in United Kingdom, including key phases of review, procedures and appeals.
NEW HAVEN, Conn., Feb. 8, 2022 /PRNewswire/ Participating companies in the Student Program to Ready Interns for Next-generation Talent (SPRINT) are actively recruiting candidates for Summer 2022 paid internships